[A05-19C] Memantine in Alzheimer's disease

Last updated 26.04.2011

Project no.:
A05-19C

Commission:
Commission awarded on 22.02.2005 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Drug Assessment

Application field:
Head and nerves

26.04.2011

Change in the IQWiG final report of 2009: proof of a benefit for cognitive function; indications of a benefit for activities of da...

Press release

02.08.2010

IQWiG supplements benefit assessment with previously unpublished studies

Press release

Accompanying information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealth.org.

Project no.	Title	Status
GA10-02	Memantine in Alzheimer’s disease: Results of the unpublished studies IE2101 and MEM-MD-22 as well as unpublished responder analyses	Commission completed
A10-06	Responder analyses for memantine in Alzheimer´s disease - Rapid report	Commission completed

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.